Lawrence D. Kingsley
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KeyBanc initiates IDEXX coverage with Sector Weight rating. KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Polaris (PII) Highlights in Q2, Target Cut, Q3 Call Scheduled. Polaris was highlighted as a top performer in the consumer discretionary leisure sector for Q2, according to a Yahoo analysis. Baird lowered its price target to $65 while keeping a neutral stance, reflecting a more cautious view. The company will host its third‑quarter 2026 earnings call and webcast later this month, providing an opportunity for updates on its financial outlook.
Transaction History
| MIR | ▲ Buy | Grant | 1,333 | $19K | 9/30/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 2,203 | $252K | 9/4/2026 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,203 | $1.2M | 9/4/2026 | View on chart |
| MIR | ▲ Buy | Grant | 1,095 | $19K | 6/30/2026 | View on chart |
| MIR | ▲ Buy | Grant | 7,383 | $0 | 5/13/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 257 | $0 | 5/7/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 82 | $0 | 5/7/2026 | View on chart |
| PII | ▲ Buy | Grant | 2,641 | $175K | 4/30/2026 | View on chart |
| MIR | ▲ Buy | Grant | 1,104 | $19K | 3/31/2026 | View on chart |
| MIR | ▲ Buy | Grant | 806 | $19K | 12/31/2025 | View on chart |
| MIR | ▼ Sell | Open Market | 350,000 | $8.7M | 12/10/2025 | View on chart |
| MIR | ▼ Sell | Gift | 40,925 | $0 | 11/24/2025 | View on chart |
| MIR | ▼ Sell | Open Market | 300,000 | $7.1M | 11/21/2025 | View on chart |
| MIR | ▲ Buy | Grant | 850 | $19K | 9/30/2025 | View on chart |
| MIR | ▼ Sell | Open Market | 350,000 | $6.3M | 5/21/2025 | View on chart |
| MIR | ▼ Sell | Open Market | 150,000 | $2.7M | 5/21/2025 | View on chart |
| MIR | ▲ Buy | Grant | 7,977 | $0 | 5/15/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 262 | $0 | 5/6/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 84 | $0 | 5/6/2025 | View on chart |
| PII | ▲ Buy | Grant | 4,320 | $150K | 5/1/2025 | View on chart |
| MIR | ▼ Sell | Gift | 1,050,000 | $0 | 11/12/2024 | View on chart |
| MIR | ▼ Sell | Other | 1,050,000 | — | 11/12/2024 | View on chart |
| MIR | ▼ Sell | Gift | 1,050,000 | $0 | 11/12/2024 | View on chart |
| MIR | ▼ Sell | Gift | 3,150,000 | $0 | 11/5/2024 | View on chart |
| MIR | ▼ Sell | Other | 3,150,000 | — | 11/4/2024 | View on chart |
| MIR | ▲ Buy | Grant | 1,785 | $0 | 6/28/2024 | View on chart |
| MIR | ▲ Buy | Grant | 13,500 | $0 | 6/4/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 257 | $0 | 5/6/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 82 | $0 | 5/6/2024 | View on chart |
| PII | ▲ Buy | Grant | 1,801 | $150K | 4/25/2024 | View on chart |
| MIR | ▲ Buy | Grant | 1,679 | $0 | 3/28/2024 | View on chart |
| MIR | ▲ Buy | Grant | 1,835 | $0 | 12/29/2023 | View on chart |
| MIR | ▲ Buy | Grant | 2,570 | $0 | 9/29/2023 | View on chart |
| MIR | ▲ Buy | Grant | 11,850 | $0 | 6/6/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 344 | $0 | 5/11/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 120 | $0 | 5/11/2023 | View on chart |
| PII | ▲ Buy | Grant | 1,380 | $150K | 4/27/2023 | View on chart |
| MIR | ▲ Buy | Grant | 14,274 | $0 | 6/15/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 224 | $0 | 5/11/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 78 | $0 | 5/11/2022 | View on chart |
| PII | ▲ Buy | Grant | 1,486 | $145K | 4/28/2022 | View on chart |
| MIR | ▲ Buy | Grant | 5,817 | $0 | 12/27/2021 | View on chart |
| MIR | ▲ Buy | Grant | 350,000 | $3.5M | 10/20/2021 | View on chart |
| MIR | ▲ Buy | Grant | 150,000 | $1.5M | 10/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Mirion Shares Rise Amid Nuclear Sector Momentum
Mirion Technologies stock has climbed recently, partly driven by broader optimism in the nuclear sector following TVA's first small modular reactor construction permit. Analysts currently hold an average price target of $24.00 for the shares. The company's valuation remains high relative to its earnings, with a trailing P/E of 164.6.
Mirion Shares Rise Amid Nuclear Sector Momentum. Mirion Technologies stock has climbed recently, partly driven by broader optimism in the nuclear sector following TVA's first small modular reactor construction permit. Analysts currently hold an average price target of $24.00 for the shares. The company's valuation remains high relative to its earnings, with a trailing P/E of 164.6.